Remove Biopharma Remove Healthcare Remove Physicians Remove Specialization
article thumbnail

Leading speciality pharmacies in pharma

Pharmaceutical Technology

Speciality pharmacies play a crucial role in medication dosing, disease and side effects management, and patient care. The expert services rendered by them help in improving patient outcomes, minimising costs of the healthcare system, improving medicinal adherence and persistency and saving clinicians’ time. Adherence management.

article thumbnail

The Caregiver Vertical: How Pharma Engages

Pharma Marketing Network

Members of a multidisciplinary care team may include physicians, nurses, pharmacists, radiologists, dieticians…the list goes on. With an estimated 65 million people serving as caregivers, 1 the role is now a factor in an ever-increasing list of healthcare priorities. But one key member is often omitted: the patient’s caregiver.

Pharma 98
Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Trending Sources

article thumbnail

Five IDNs to watch in 2023

Clarivate

healthcare provision landscape, integrated delivery networks, or IDNs, are differentiating their offerings by adding outpatient treatment centers, pursuing National Cancer Institute designations and investing in value-based care. Christopher Silva, Senior Healthcare Research Analyst. Pillo, Senior Healthcare Research Analyst.

article thumbnail

Handling Economic Uncertainty: The Focus Pharma Marketers Need

Eversana Intouch

Biopharma valuations are down, especially for public and earlier-stage companies. Talent shortages continue, particularly in executive and specialized R&D roles, while simultaneously layoffs , especially in biotech, are on the rise. Healthcare delivery was unable to recover after the peak of the pandemic, and is still limping.

article thumbnail

Handling Economic Uncertainy: The Focus Pharma Marketers Need

Eversana Intouch

Biopharma valuations are down, especially for public and earlier-stage companies. Talent shortages continue, particularly in executive and specialized R&D roles, while simultaneously layoffs , especially in biotech, are on the rise. Healthcare delivery was unable to recover after the peak of the pandemic, and is still limping.

article thumbnail

For rare disease patients in Mainland China, hope of greater access to treatment

Clarivate

The consortium aims to promote awareness for rare diseases within the healthcare community and general public, address the impending issue of drug availability and improve the quality of life of rare disease patients. Gain access to intelligence on Mainland China’s healthcare market and disease-specific trends. References. [1]

article thumbnail

Digital health investors getting choosier as sector matures

pharmaphorum

The public listing market slumped to nine initial public offerings (IPOs) and five special purpose acquisition company (SPAC) deals in 2022, but partnering remained buoyant, with more than 2,900 deals signed. Roche tops biopharma partnering podium.